Edgepharma Limited LONDON


Founded in 2017, Edgepharma, classified under reg no. 10581135 is an active company. Currently registered at Milner House W1U 3PP, London the company has been in the business for 7 years. Its financial year was closed on Sunday 30th June and its latest financial statement was filed on 2022/06/30.

The firm has one director. Geoffrey M., appointed on 24 January 2017. There are currently no secretaries appointed. As of 26 April 2024, our data shows no information about any ex officers on these positions.

Edgepharma Limited Address / Contact

Office Address Milner House
Office Address2 14 Manchester Square
Town London
Post code W1U 3PP
Country of origin United Kingdom

Company Information / Profile

Registration Number 10581135
Date of Incorporation Tue, 24th Jan 2017
Industry Other service activities not elsewhere classified
End of financial Year 30th June
Company age 7 years old
Account next due date Sun, 31st Mar 2024 (26 days after)
Account last made up date Thu, 30th Jun 2022
Next confirmation statement due date Thu, 17th Oct 2024 (2024-10-17)
Last confirmation statement dated Tue, 3rd Oct 2023

Company staff

Geoffrey M.

Position: Director

Appointed: 24 January 2017

Limestar Investments Limited

Position: Corporate Secretary

Appointed: 24 January 2017

Resigned: 04 May 2022

People with significant control

The list of PSCs that own or control the company includes 1 name. As BizStats identified, there is Geoffrey M. This PSC has 75,01-100% voting rights and has 75,01-100% shares.

Geoffrey M.

Notified on 24 January 2017
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Annual reports financial information

Profit & Loss
Accounts Information Date 2018-06-302019-06-302020-06-302021-06-302022-06-302023-06-30
Balance Sheet
Cash Bank On Hand1 049 9441 749 40112 04820 252126 04744 087
Current Assets1 147 1732 596 362109 009117 213223 008209 721
Debtors97 230846 96196 96196 96196 961165 634
Net Assets Liabilities32 74313 713-227 819-219 616-220 279-237 394
Other Debtors268  -1 559 68 673
Other
Accrued Liabilities Deferred Income9 1801 2261 2261 2261 2266 226
Administrative Expenses64 84044 029261 7372 60366332 228
Cash Cash Equivalents Cash Flow Value1 049 9421 749 40112 04820 252126 04744 087
Comprehensive Income Expense32 741-19 030-241 5328 203-663-17 115
Corporation Tax Recoverable   1 559  
Creditors9 1802 582 649336 828336 829443 287447 115
Current Tax For Period7 956     
Gain Loss In Cash Flows From Change In Accrued Items9 180-7 954   5 000
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables1 105 2501 476 173-2 245 8211106 458-1 172
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables-97 229-749 732750 000  -68 673
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss-17 926-13117 272621-621-5 601
Gross Profit Loss105 53925 00020 23010 806 15 113
Income Taxes Paid Refund Classified As Operating Activities7 956     
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation1 049 942699 457-1 737 3538 204105 795-81 960
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings2125   
Interest Paid Classified As Operating Activities2125   
Interest Payable Similar Charges Finance Costs2125   
Net Cash Flows From Used In Operating Activities1 049 942699 457-1 737 3538 204105 795-81 960
Net Cash Generated From Operations1 057 900699 458-1 737 3288 204105 795-81 960
Net Current Assets Liabilities1 137 99413 713-227 819-219 616-220 279-237 394
Number Shares Issued Fully Paid111111
Operating Profit Loss40 699-19 029-241 5078 203-663-17 115
Other Taxation Social Security Payable 1 1731 1731 1731 173 
Par Value Share122222
Profit Loss32 741-19 030-241 5328 203-663-17 115
Profit Loss On Ordinary Activities Before Tax40 697-19 030-241 5328 203-663-17 115
Revenue From Rendering Services 25 00020 230   
Tax Tax Credit On Profit Or Loss On Ordinary Activities7 956     
Total Assets Less Current Liabilities1 137 99413 713-227 819-219 616-220 279-237 394
Trade Creditors Trade Payables1 105 2502 580 250334 429334 430440 888440 889
Trade Debtors Trade Receivables96 961846 96196 96196 96196 96196 961
Turnover Revenue105 53925 00020 23010 806 15 113
Number Shares Allotted2     

Company filings

Filing category
Accounts Address Confirmation statement Incorporation Officers Persons with significant control
Confirmation statement with no updates 2023/10/03
filed on: 18th, October 2023
Free Download (3 pages)

Company search

Advertisements